Financhill
Back

Cordyceps Sunshine Biotech Holdings Co., Ltd. 10K Form

Sell
29

RAJAF
Cordyceps Sunshine Biotech Holdings Co., Ltd.

Last Price:
$5.20
Seasonality Move:
-6.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RAJAF News And Ratings

See the #1 stock for the next 7 days that we like better than RAJAF

RAJAF Financial Statistics

Sales & Book Value

Annual Sales: $1.3M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 0

Profitability

Net Income (TTM): $0
Gross Margin: $109.7K
Return on Equity: 0%
Return on Assets: 0%

Key Cordyceps Sunshine Biotech Holdings Co., Ltd. Financial Ratios

  • The Gross Profit Margin over the past 5 years for RAJAF is 8.75%.
  • The Selling, General & Administrative Expenses for RAJAF have been equal to 57.26% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Net Earning history of RAJAF is -18.05% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Personal Care Products
Sector: Consumer Staples
Current Symbol: RAJAF
Website: cordyceps-sunshine.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 856
Forward P/E Ratio: 0

RAJAF Technical Analysis vs Fundamental Analysis

Sell
29
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) is a Sell

Is Cordyceps Sunshine Biotech Holdings Co., Ltd. a Buy or a Sell?